Cargando…

Inhaled Antibiotic Therapy in Chronic Respiratory Diseases

The management of patients with chronic respiratory diseases affected by difficult to treat infections has become a challenge in clinical practice. Conditions such as cystic fibrosis (CF) and non-CF bronchiectasis require extensive treatment strategies to deal with multidrug resistant pathogens that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maselli, Diego J., Keyt, Holly, Restrepo, Marcos I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454974/ https://www.ncbi.nlm.nih.gov/pubmed/28509852 http://dx.doi.org/10.3390/ijms18051062

Ejemplares similares

Prevention of ventilator-associated pneumonia in the intensive care unit: A review of the clinically relevant recent advancements
por: Keyt, Holly, et al.
Publicado: (2014)

Profile of lebrikizumab and its potential in the treatment of asthma
por: Maselli, Diego Jose, et al.
Publicado: (2015)

Safety and efficacy of methylprednisolone versus dexamethasone in critically ill patients with COVID-19 acute respiratory distress syndrome: a retrospective study
por: Kellogg, Dean, et al.
Publicado: (2023)

Suspecting non‐cystic fibrosis bronchiectasis: What the busy primary care clinician needs to know
por: Maselli, Diego J., et al.
Publicado: (2017)

Inhaled protein/peptide-based therapies for respiratory disease
por: Fellner, Robert C., et al.
Publicado: (2016)

Inhaled Antibiotics for Mycobacterial Lung Disease
por: Banaschewski, Brandon, et al.
Publicado: (2019)

The future of inhalation therapy in chronic obstructive pulmonary disease
por: Cazzola, Mario, et al.
Publicado: (2022)

Inhaled Therapy in Respiratory Disease: The Complex Interplay of Pulmonary Kinetic Processes
por: Borghardt, Jens Markus, et al.
Publicado: (2018)

Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy?
por: Tashkin, Donald P, et al.
Publicado: (2018)

Pneumonia in Patients with Chronic Obstructive Pulmonary Disease
por: Restrepo, Marcos I., et al.
Publicado: (2018)

Authors’ response
por: Keyt, H., et al.
Publicado: (2015)

Establishing Antimicrobial Susceptibility Testing Methods and Clinical Breakpoints for Inhaled Antibiotic Therapy
por: Ekkelenkamp, Miquel B, et al.
Publicado: (2022)

Inhaled Antibiotics for the Prevention of Respiratory Tract Infections in Children With a Tracheostomy
por: Jutras, Camille, et al.
Publicado: (2021)

Chronic Respiratory Infection in Patients with Chronic Obstructive Pulmonary Disease: What Is the Role of Antibiotics?
por: Miravitlles, Marc, et al.
Publicado: (2017)

Antibiotic resistance in chronic respiratory diseases: from susceptibility testing to the resistome
por: Pailhoriès, Hélène, et al.
Publicado: (2022)

It's not all about inhaled treatment: challenges with oral therapy in paediatric respiratory medicine
por: Sareen, Anneka, et al.
Publicado: (2021)

Inhaled glycopyrrolate for the treatment of chronic obstructive pulmonary disease
por: Tashkin, Donald P, et al.
Publicado: (2018)

Global impact of bronchiectasis and cystic fibrosis
por: Redondo, Margarida, et al.
Publicado: (2016)

Inhaled antibiotic-loaded polymeric nanoparticles for the management of lower respiratory tract infections
por: Rahman Sabuj, Mohammad Zaidur, et al.
Publicado: (2021)

Inhaled nitric oxide: role in the pathophysiology of cardio-cerebrovascular and respiratory diseases
por: Signori, Davide, et al.
Publicado: (2022)

Role of inhaled antibiotics in the era of highly effective CFTR modulators
por: Elborn, J. Stuart, et al.
Publicado: (2023)

Current and Emerging Inhaled Antibiotics for Chronic Pulmonary Pseudomonas aeruginosa and Staphylococcus aureus Infections in Cystic Fibrosis
por: Li, Danni, et al.
Publicado: (2023)

Single-inhaler triple therapy in patients with chronic obstructive pulmonary disease: a systematic review
por: Langham, Sue, et al.
Publicado: (2019)

Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat(®) Soft Mist(™) Inhaler
por: Hodder, Richard, et al.
Publicado: (2009)

Procalcitonin in respiratory disease: use as a biomarker for diagnosis and guiding antibiotic therapy
por: Creamer, Andrew W., et al.
Publicado: (2019)

The Treatment of Pulmonary Diseases and Respiratory-Related Conditions with Inhaled (Nebulized or Aerosolized) Glutathione
por: Prousky, Jonathan
Publicado: (2008)

Inhaled Antibiotics and Airway Bacterial Decolonization for Patients with Chronic Obstructive Pulmonary Disease: The Rationale and Future
por: Han, Yaopin, et al.
Publicado: (2022)

Is there room for further innovation in inhaled therapy for airways disease?
por: Biddiscombe, Martyn F., et al.
Publicado: (2018)

Continued Innovation in Respiratory Care: The Importance of Inhaler Devices
por: Bosnic-Anticevich, Sinthia Zrinka
Publicado: (2018)

Inhalation monoclonal antibody therapy: a new way to treat and manage respiratory infections
por: Parray, Hilal Ahmad, et al.
Publicado: (2021)

Treatment with inhaled corticosteroids in chronic obstructive pulmonary disease
por: Janson, Christer
Publicado: (2020)

On the Inhalation of Carbolic Acid in Diseases of the Respiratory Organs
por: Munro, Robert
Publicado: (1880)

Inhalation of Medicated Vapors in Diseases of the Respiratory Organs
Publicado: (1882)

From the infant to the geriatric patient—Strategies for inhalation therapy in asthma and chronic obstructive pulmonary disease
por: Hagmeyer, Lars, et al.
Publicado: (2023)

Clinical evaluation of the role of ceftaroline in the management of community acquired bacterial pneumonia
por: Maselli, Diego J, et al.
Publicado: (2012)

Inhaled siRNA Formulations for Respiratory Diseases: From Basic Research to Clinical Application
por: Fan, Yulin, et al.
Publicado: (2022)

Harnessing the Potential of Enzymes as Inhaled Therapeutics in Respiratory Tract Diseases: A Review of the Literature
por: Vanderstocken, Gilles, et al.
Publicado: (2022)

The immunomodulatory effects of macrolide antibiotics in respiratory disease
por: Pollock, Jennifer, et al.
Publicado: (2021)

Comparing Inhaler Use Technique Based on Inhaler Type in Elderly Patients with Respiratory Disease
por: Lee, Ha Youn, et al.
Publicado: (2021)

Inhaled Pollutants: The Molecular Scene behind Respiratory and Systemic Diseases Associated with Ultrafine Particulate Matter
por: Traboulsi, Hussein, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rirms5b88j319dr4i7dnkkrakj